Société Internationale d'Urologie
- Country
- 🇨🇦Canada
- Ownership
- -
- Established
- 1907-01-01
- Employees
- -
- Market Cap
- -
- Website
- https://www.siu-urology.org
Clinical Trials
3
Trial Phases
0 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
BPH Global Registry
- Conditions
- Benign Prostatic HyperplasiaLower Urinary Tract Symptoms
- First Posted Date
- 2022-09-16
- Last Posted Date
- 2025-05-18
- Lead Sponsor
- Société Internationale d'Urologie
- Target Recruit Count
- 7500
- Registration Number
- NCT05543200
- Locations
- 🇺🇸
Keck Medicine of USC, Los Angeles, California, United States
🇨🇦Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada
🇨🇦McGill University Health Centre, Montréal, Quebec, Canada
Ureteral Stenting After Ureteroscopy for Stone Treatment, A Global Perspective on Indications and Outcomes
- Conditions
- Stone UreterStone;RenalStone, Kidney
- First Posted Date
- 2018-06-25
- Last Posted Date
- 2021-04-13
- Lead Sponsor
- Société Internationale d'Urologie
- Target Recruit Count
- 2348
- Registration Number
- NCT03567421
- Locations
- 🇺🇸
University of Minnesota, Minneapolis, Minnesota, United States
🇨🇳Guangdong Second Provincial General Hospital, The Third Clinical Medical College of Southern Medical University, Guangzhou, Guangdong, China
🇨🇳The First Affiliated Hospital of Guangzhou Medical University and Guangdong Key Laboratory of Urology, Guangzhou, China
Benign Prostatic Hyperplasia (BPH) Mobile Application Pilot Study
- Conditions
- Lower Urinary Tract SymptomsProstatic Hyperplasia
- First Posted Date
- 2017-07-25
- Last Posted Date
- 2025-05-18
- Lead Sponsor
- Société Internationale d'Urologie
- Target Recruit Count
- 200
- Registration Number
- NCT03228485
- Locations
- 🇬🇷
University Hospital of Larissa, Institute for Monitoring of Urogenital Diseases, Larissa, Greece
🇮🇹University of Florence, Florence, Italy
🇵🇹Hospital de Santo Antonio, Porto, Portugal